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Introduction: Since the early 1990s, many studies have shown lower mortality for abdominal aortic aneurysm (AAA)
repair at high-volume centers compared with low-volume centers. The introduction of endovascular AAA repair (EVAR)
also has changed the practice of AAA repair. The goal of this study was to determine if regionalization of AAA repair
occurred in the United States. Etiologic factors were examined in addition to any reduction in operative mortality rates.
Methods: Patient discharges of nonruptured AAA repair were identified from the Nationwide Inpatient Sample between
1998 and 2004. Hospitals were stratified by yearly AAA surgical volume of low (<17 cases), medium (18 to 50), and high
(>50).
Results: A total of 46,901 patients underwent AAA repair (72.7% open vs 27.3% endovascular). The percentage of AAA
repairs performed at both low-volume (36.2% to 24.3%) and medium-volume (51.0% to 44.8%) centers fell; whereas, the
percentage performed at high-volume centers nearly tripled (12.9% vs 30.9%). In 1998 there were 10 high-volume
centers; by 2004 this had increased to 26. The number of low-volume centers decreased, from 412 to 328. EVAR was
more rapidly adopted by high-volume centers compared with low-volume centers. By 2004, 64.3% of AAA repairs at
high-volume centers were done with endovascular techniques compared with 31.8% in low-volume centers. A concurrent
reduction occurred in patient mortality, from 4.4% in 1998 to 2.5% in 2004 (P < .0001).
Conclusion: Between 1998 and 2004, a trend towards the regionalization of AAA repair to high-volume centers occurred.
Nearly one-third of all AAA repairs were performed at high-volume centers. There was a concurrent increase in the
frequency of endovascular AAA repair, especially at high-volume centers. During this period of regionalization of AAA
repair to high-volume centers, patient mortality after AAA repair decreased by 23%. Thus, the observed regionalization
of AAA repair and the reduction in short-term patient mortality for this operation may be explained by increased
utilization of endovascular technologies at high-volume centers. ( J Vasc Surg 2008;48:29-36.)The risk of postoperative morbidity and mortality after
complex operations is significantly lower at high-volume
centers compared with low-volume centers.1-3 Although
the underlying cause of this effect continues to be debated,
the concept of a volume– outcome relationship has been
shown to influence survival for elective abdominal aortic
aneurysm (AAA) repair.4 In 2007 Killeen et al5 published
an extensive review of the available literature on the vol-
ume– outcome relationship in elective AAA repair. This
meta-analysis largely comprised studies done before the
endovascular era. They found a 3% to 11% reduction in the
relative risk of morbidity for patients operated on at high-
volume centers compared with low-volume centers.5
Private insurers and health care advocacy groups have
used these findings to stratify hospitals according to oper-
ative volume.6,7 In 2000 the Leapfrog Group, a coalition of
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doi:10.1016/j.jvs.2008.02.048150 large health care purchasers, defined high-volume
centers for AAA repair as those that performed 50 elective
AAA repairs per year. In 2003 the Leapfrog Group sug-
gested that their member employers regionalize the care of
elective AAA repair by referring only to high-volume cen-
ters.7
Concurrent with this dialogue, endoluminal therapy of
AAA was introduced as an alternative to traditional open
repair. The first reports of endoluminal therapies for the
treatment of AAA were presented in the early 1990s.8,9 In
1999 the United States Food and Drug Administration
(FDA) approved two endoluminal devices for the elective
treatment of AAA. Since that time, multiple other stent
graft devices have been introduced and have received FDA
approval.
Endovascular AAA repair (EVAR) has been shown to
have lower mortality rates compared with open aortic repair
in the immediate perioperative period; however, long-term
outcomes appear to be equivalent.10-14 The adoption of
EVAR has been rapid. Using the Nationwide Inpatient
Sample (NIS), Nowygrod et al15 reported that 43.0% of
AAA repairs were performed by EVAR in 2003. In 2006
Forbes et al16 suggested that the introduction of EVAR has
centralized the care of elective AAA to larger-volume cen-
ters within Canada.
The aim of this study is to determine whether the
regionalization of elective AAA repair has occurred through
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was limited to elective AAA repair in order to limit any
confounding effects introduced by the inclusion of rup-
tured AAA repair. We investigated the regionalization of
AAA repair to high-volume centers and its influence on the
operative mortality rate. Because the examined time frame
included the introduction of endovascular technologies for
AAA repair, we also determined the relative frequency and
outcome of open vs EVAR and how this may have influ-
enced these national trends. We propose that the early
availability of EVAR techniques at high-volume centers
may have further broadened their referral bases, thus accel-
erating the regionalization of AAA repair to high-volume
centers.
METHODS
This study used the NIS to perform a retrospective
observational study for the years 1998 to 2004. Managed
by the Healthcare Cost and Utilization Project, the NIS is
the largest all-payer database of hospital discharges in the
United States, providing a 20% stratified sample of all
nonfederal hospitals, including academic and specialty hos-
pitals. All patients discharged from member hospitals are
included for the given year.
The NIS is a weighted stratified sample that allows for
the calculation of national population estimates from the
sampled data. The stratification schema of the NIS aims to
provide a representative sample of the US population each
year. The hospitals included in NIS are stratified using (1)
geographic region, (2) urban vs rural, (3) teaching status,
(4) for-profit status, and (5) bed size. The stratification
criteria have not changed since 1998, thus comparisons
across study years are valid.
NIS patient data are linked to hospital data provided by
the American Hospital Association (AHA) annual survey of
hospitals. This linkage provides demographic data for the
hospital, including rural vs urban status, teaching vs non-
teaching, and hospital size. Teaching status is defined as the
presence of one of the following criteria: (1) Council of
Teaching Hospitals and Health Systems membership, (2) a
American Medical Association-approved residency pro-
gram, or (3) an intern-plus-resident/bed ratio 0.25.
Patients with the primary diagnosis code of nonrup-
tured AAA (441.4) were queried using codes from the
International Classification of Disease, 9th Edition. Only
adult records associated with operative treatment were
analyzed (Table I).
Although the sampling frame has not changed between
1998 and 2004, the actual hospitals that were sampled
varied yearly. Thus, it is not possible to trend the operative
volume of individual hospitals by using the NIS. Instead,
the NIS provides a mechanism to evaluate national trends
across multiple years by providing a validated stratified
sample of US hospitals.17
Statistical analysis. All analyses were performed with
SAS 9.1 software (SAS institute, Cary, NC). The primary
outcome measure was yearly number of AAA repairs per-
formed per hospital. Yearly counts of the number of AAArepairs performed by individual hospitals were calculated
using the AHA hospital information provided by the NIS.
To account for hospitals with low case volumes and to
delineate those with nonsuccessive years of sampling by the
NIS, the performance of appendectomies was included as a
control. Thus, if a hospital performed no AAA repairs and
no appendectomies in a given year, then it was deemed to
be not included in that year’s NIS sample; however, if a
hospital performed one or more appendectomies and no
AAA repairs in that year, then the number of AAA repairs
equaled zero for that year.
The yearly count of AAA repairs for both total opera-
tions and EVAR cases was used to assign hospitals to one of
three Leapfrog Group volume categories: (1) low volume,
zero to 18 AAA repairs, (2) medium volume, 18 to 49, and
(3) high volume,50. Volume assignments were provided
on a yearly basis. The Leapfrog volume classifications were
chosen for this study because the Leapfrog Group is one of
the most commonly cited patient-advocacy groups. These
cutoffs were developed before the endovascular era and
thus do not provide direct evidence for the number of
EVAR repairs that should be performed to maintain com-
petency. To our knowledge, no published reports have
described the volume–outcome relationship for EVAR.
Thus, we believe that the Leapfrog strata provide the best
approximation of the volume strata for open and endovas-
cular AAA repair.
The number of hospitals assigned in each of the three
volume categories and the number of operations performed
by each volume strata were analyzed. A Mantel-Haenszel
test of trend was performed to assess for statistical signifi-
cance.
A survey-weighted multivariable logistic regression was
performed. In-hospital mortality was the dependent vari-
able, and covariates included patient sex, age group (60,
60 to 79, and 80 years), and the presence of concurrent
comorbidities such as diabetes mellitus, liver failure, renal
failure, and congestive heart disease. The presence of these
comorbidities was defined by previously validated software
developed for the purpose of extractingmedical comorbidi-
ties from national data sets such as the NIS.18,19 Other
patient level covariates included type of payer, type of
Table I. Listing of International Classification of Disease,
9th Edition codes used for analysis
Code Description
Diagnosis
441.4 Abdominal aortic aneurysm without mention
of rupture
Procedure
38.34 Resection of vessel with anastomosis, aorta
38.44 Graft replacement (interposition),
abdominal, aorta
39.71 Endovascular repair of abdominal aortic
aneurysm with graftoperation performed (open vs EVAR) and year of opera-
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size, and Leapfrog volume assignment were also evaluated.
RESULTS
Demographics. The NIS included records (weighted,
230,615) of 46,901 patients (79% men) who underwent
repair of nonruptured AAAs between 1998 and 2004. The
mean age of all patients within the sample was 72.2 (stan-
dard error, 0.06; range, 18-102) years. Of these, 91.5%were
white, 3.1%were black, 3.4%were classified as other races, and
no racial information provided for 1.8%. A further comparison
of the two groups is provided in Table II.
Univariate analysis
Demographics. The perioperative mortality rate for
women was higher than that of men by univariate analysis,
at 5.0% vs 3.0% (P  .0001). African Americans had the
highest mortality of any race, at 6.2%; with whites at 3.5%,
Hispanics at 4.8%, Asians at 3.7%, and Native Americans at
4.6% (overall P .0001). Age was a significant predictor of
perioperative death. The mortality rate for patients aged
80 years was 6.2% compared with 0.8% for patients aged
60 years, and age 60 to 80 years had an intermediate
mortality rate of 3.0% (overall P .0001).
Operative characteristics. Between 1998 and 2004,
34,102 patients (72.7%) undergoing AAA repair had an
Table II. Patient characteristics for all patients undergoin
2004
Overall Low
Patients, No. (%) 46,901 13,214 (28
Patient characteristics
Age, mean (SEM) y 72.2 (0.06) 72.0 (0.
Patient sex, %
Male 79.3 27.1
Female 20.7 29.7
Patient race, %a
White 91.5 26.1
African American 3.1 34.5
Hispanic 2.4 46.9
Asian 1.1 52.8
Native American 0.1 24.9
Payer, %
Medicare 76.5 27.0
Private/HMO 20.2 28.8
Medicaid/self-pay 2.0 35.9
No charge/other 1.3 33.9
Hospital characteristics
Teaching status, %
Nonteaching 44.1 68.2
Teaching 55.9 31.8
Hospital bed size, %
Small 6.4 14.9
Medium 20.3 37.1
Large 73.2 48.0
HMO, Health maintenance organization; SEM, standard error of the mean
aNo information on race was provided for 1.8%.open procedure, whereas 12,799 (72.7%) underwentEVAR. Corresponding to both the adoption of EVAR
technologies by an increasing number of surgeons and the
creation of a separate ICD-9 code for this procedure, two
different eras of AAA repair were observed within the study
period. Before 2000, conventional open repairs were done
in 99.9% of patients who underwent AAA repair. Beginning
in 2000, 7.8% of patients were treated with EVAR, and by
Fig 1. Adoption of endovascular aneurysm repair technology
since 2000 for low- (white bars), medium- (gray bars), and high-
volume (black bars) centers.
air of abdominal aortic aneurysm between 1988 and
Hospital volume level
PMedium High
20,021 (42.7) 13,666 (29.1)
72.2 (0.08) 72.5 (0.16)
.0001
42.7 30.1
41.4 28.8
.0001
42.9 31.0
40.1 25.5
27.4 25.7
30.2 17.0
57.4 17.7
.0008
42.6 30.4
42.3 28.9
36.7 27.3
47.1 18.9
.0001
46.0 18.6
54.0 81.4
.0001
4.8 0.9
20.0 4.9
75.2 94.2g rep
.2)
08)
.2004, 52.0% of patients were treated with EVAR vs 48.0%
12.
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treated through conventional open repair than men (78.5
vs 71.2%; overall 2, P .0001). Patients who were treated
by open repair were significantly younger than patients who
underwent EVAR (71.7 vs 73.5 years; P  .0001). Open
AAA repair was associated with a 4.4% risk of death com-
pared with 1.2% for EVAR (P  .0001).
Hospital volume. Hospitals performed an average of
13.6 AAA open and endovascular repairs per year between
1998 and 2004. Hospitals were stratified according to the
Leapfrog Group volume criteria. The Leapfrog Group used
the yearly case volume for each hospital between 1998 and
2004 to classify 75.0% of hospitals as low volume (17
AAA repairs per year), 19.5% asmedium volume (18 to 49),
and 5.5% as high volume (50).
For men, 27.1% underwent repair at low-volume
centers, 41.3% at medium-volume centers, and 31.6% at
high-volume centers; for women, the rate was 29.7% at
low-volume, 40.1% at medium-volume, and 30.2% at
high-volume centers (P  .001). A larger percentage of
patients aged 80 years were operated on at high-
volume centers compared with patients 60 years
(33.3% vs 30.6%; P  .009). Whites (32.5%) were more
likely to have AAA repairs performed at high-volume
centers compared with African Americans (27.0%), His-
panics (26.0%), and Asians (17.0%; P  .0001).
Most nonteaching hospitals were low- and medium-
volume centers (87.4%); whereas, only 56.4% of teaching
hospitals were low- and medium-volume centers (P 
.0001). Hospital size was associated with case volume:
smaller hospitals had lower case volumes than larger hospi-
tals (P  .0001). Rural vs urban classification was highly
predictive of volume status: Only 3.4% of rural hospitals
were designated as high-volume centers, whereas 29.2% of
urban centers achieved this status (Table II).
Yearly trends. An increase was observed in the mean
number of AAA repairs performed per hospital between
Table III. Trends in number of hospitals, total cases, and
low-, medium-, and high-volume centers between 1998 an
Volume level 1998 1999
Low
No. of hospitals 412 399
Total cases 2102 2102 1
No. of cases, mean/y 5.1 5.3
Medium
No. of hospitals 101 96
Total cases 2962 2853 2
No. of cases, mean/y 29.3 29.7
High
No. of hospitals 10 18
Total cases 748 1280 1
Cases, mean/y 74.8 71.1
Overall
No. of hospitals 523 513
Total cases 5812 6235 5
No. of cases, mean/y 11.1 12.21998 and 2004, from 11.1 per year to 15.4. Mean hospitalvolume rose to a greater extent in high-volume centers
compared with low-volume centers. Low-volume centers
performed a yearly average of 5.1 operations in 1998 and
5.3 operations in 2004. This contrasted with high-volume
centers, whose yearly operative volume for AAA repair
increased from 74.8 in 1998 to 84.9 in 2004 (Table III).
An examination of the proportion of operations per-
formed at low-, medium-, and high-volume hospitals ac-
cording to Leapfrog Group criteria demonstrated that a
higher percentage of cases were performed at low- and
medium-volume centers in 1998 (36.2% and 51.0%, re-
spectively) compared with the percentage of total cases
performed in 2004 (24.3% and 44.8%). Total cases per-
Fig 2. Percentage of abdominal aortic aneurysm repairs per-
formed by hospitals of low- (black bars), medium- (gray bars), and
high-volume (white bars) classification between 1998 and 2004.
n number of cases per year for AAA repair performed at
04
2001 2002 2003 2004
366 347 356 328
1744 1788 1852 1733
0 4.8 5.2 5.2 5.3
104 94 92 110
2945 2830 2731 3203
1 28.3 30.1 29.7 29.1
33 33 33 26
2890 2379 2679 2208
7 87.6 72.1 79.6 84.9
503 474 481 464
7579 6997 7210 7144
1 15.1 13.8 15.0 15.4mea
d 20
2000
377
893
5.
89
497
28.
22
534
69.
488
924formed at high-volume centers nearly tripled between
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icance was tested by Mantel-Haenszel 2 test (P  .001).
The actual number of hospitals classified as low-,
medium-, and high-volume centers differed between 1998
and 2004 (P  .0001). Between 1998 and 2004, the
number of hospitals designated as high-volume centers
increased from 10 to 26. There was a concomitant reduc-
tion, from 412 to 328, of low-volume centers performing
AAA repair, a decrease of approximately 20%. The number
of medium-volume centers remained about the same (Ta-
ble III).
EVAR trends. Utilization of EVAR was correlated
with volume strata. Low-volume centers were less likely to
adopt endovascular techniques than high-volume centers.
In 2001, low-volume centers used endovascular techniques
to perform15.6% of their AAA repairs. In comparison,
EVAR comprised 46.9% of operations by high-volume
centers at that time. By 2004, 62.9% of AAA repairs per-
formed at high-volume centers were endoluminal, whereas
only 34.2% of cases performed at low-volume centers were
endoluminal (Fig 1). In 2000, no hospitals performed50
AAA repairs using EVAR technologies; however, in 2001,
13 hospitals achieved this high-volume classification for
EVAR techniques. The number of high-volume EVAR
centers remained similar, from 13 in 2001 to 11 in 2004,
but the average number of cases performed at these centers
increased yearly from 71.2 in 2001 to 85.6 in 2004. The
number of medium-volume centers for EVAR stabilized by
2002 at approximately 50 centers nationwide. A small
increase in the number of AAA repairs performed using
EVAR at these centers was observed between 2001 and
2004.
Multivariable analysis
Mortality rate. Amultivariable Cox proportional haz-
ards model was performed to define the factors indepen-
dently influencing in-hospital mortality after elective AAA
repair (Table IV). Increasing patient age was highly predic-
tive of an increased risk of mortality (P  .0001). The
mortality rate was 0.8% for those patients aged 60, 3.1%
for individuals aged 60 to 79 years, and 6.4% for patients
aged80 years. The risk of mortality was higher in women
than in men (5.1% vs 3.1%), with an adjusted odds ratio
(OR) of 1.4 (95% confidence interval [CI] 1.3-1.6; P 
.0001). The presence of liver and renal failure indepen-
dently increased the odds of mortality (P .0001 for each).
Diabetes mellitus appeared to have a protective effect, as
patients who were diagnosed with diabetes mellitus had
improved in-hospital survival compared with those with no
prior diagnoses of diabetes mellitus (P .004). A listing of
the relative frequencies of comorbidities used in the Cox
regression can be found in the Appendix (online only).
Patients with private insurance had improved survival
of 2.0% compared with 3.9% for those with Medicare
(adjusted OR, 0.7; 95% CI, 0.6-0.9). Endovascular repair
was independently associated with significantly reduced risk
of mortality compared with open repair (adjusted OR, 0.3;
95% CI, 0.2-0.3).Hospital size was not independently predictive of in-
hospital mortality in the Cox model, with large sized at
3.3% vs small at 4.1% (adjusted OR, 1.1; 95% CI, 0.8-1.4)
and medium sized at 3.9% vs small 4.1%, (adjusted OR 1.2,
95% CI, 0.9-1.5). Hospital volume for AAA affected mor-
tality. Compared to low-volume centers, the risk of death
was significantly reduced at medium-volume centers (ad-
justed OR, 0.7; 95% CI, 0.6-0.8) and high-volume centers
(adjusted OR, 0.6; 95% CI, 0.5-0.7).
High-volume centers adopted EVAR more quickly
and to a greater extent than low-volume centers. The
protective effects of EVAR attenuated the effect of year
on mortality in the above Cox model. The univariate
analysis showed a significant trend in the reduction of
patient mortality between 1998 and 2004 (Mantel-
Haenszel test of trend, P  .0001; Fig 3). However,
there was no effect of year in the multivariate analysis
(adjusted OR, 1.0; 95% CI 1.0-1.0).
DISCUSSION
This is the first published report, to our knowledge, to
Table IV. Multivariate Cox proportional hazard analyses
of mortality after controlling for patient and hospital-level
covariates
Covariates HR (95% CL) P
Comorbidities
No disease Referent
Diabetes 0.74 (0.6, 0.9) .002
Liver failure 3.4 (2.4, 4.9) .0001
Renal failure 4.7 (4.0, 5.5) .0001
CHF 11.8 (8.1, 17.0) .0001
Patient sex .0001
Male Referent
Female 1.4 (1.3, 1.6)
Age group, years .0001
60 Referent
60-79 3.3 (2.1, 5.1)
80 7.3 (4.7, 11.4)
Payer .009
Medicare Referent
Medicaid/self-pay 0.9 (0.6, 1.4)
No charge/other 1.0 (0.6, 1.6)
Private/HMO 0.7 (0.6, 0.9)
Teaching hospital .77
Yes Referent
No 0.9 (0.8, 1.1)
Hospital Size .30
Small Referent
Medium 1.2 (0.9, 1.5)
Large 1.1 (0.8, 1.4)
Operative volume .0001
Low Referent
Medium 0.7 (0.6, 0.8)
High 0.6 (0.54, 0.7)
Year 1.0 (1.0, 1.0) .0001
Type of repair .0001
Open Referent
Endovascular 0.3 (0.2, 0.3)
CHF, Congestive heart failure; CL, confidence limits; HMO, health main-
tenance organization; HR, hazard ratio.demonstrate that the regionalization of elective AAA repair
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tional data set, we showed that high-volume centers per-
formed an increasing proportion of AAA repairs from 1998
to 2004 and that the number of high-volume centers rose
with a concurrent fall in low-volume centers. It is unlikely
that these findings are solely a result of low-volume and
medium-volume hospitals increasing their operative vol-
ume. In 1998, 412 centers were in the low-volume strata;
however, by 2004 this number was 328. This reduction of
nearly 100 hospitals in the low-volume strata corresponded
to the formation of only 16 new high-volume centers and
an unchanging number of medium-volume centers. The
underlying reasons driving the shift in cases from low-
volume centers to high-volume centers are likely multifac-
torial and may include centralizing forces secondary to the
introduction of EVAR or regionalization of care due to the
relationship between hospital volume and outcome, or
both.
The introduction and rapid adoption of endovascular
aortic stents for the repair of AAAs occurred during our
study period. The FDA approved the first device for EVAR
in 1999, and a separate ICD-9 code was created in 2000.
Therefore, most AAA repairs performed before 2000 can
be assumed to be open repairs. Owing to the high initial
start-up costs associated with endovascular repairs, we pro-
pose that low-volume centers were initially less likely to
adopt endovascular techniques than high-volume centers.
In 2004, high-volume centers were nearly twice as likely to
perform a given AAA repair by endoluminal techniques as
low-volume centers (62.9% of AAAs vs 34.2%).
Although a causal relationship cannot be proven, we
propose that the introduction of EVAR technology greatly
influenced the regionalization of elective AAA repairs more
Fig 3. The mortality rate in patients undergoing abdominal aor-
tic aneurysm repair was significantly reduced between 1998 and
2004 (Mantel-Haenszel test of trend, P .0001). Shown in heavy
solid line is the overall mortality, light gray lines represent open
repair, and dashed lines represent endovascular aneurysm repair
(EVAR).than any other factors because the growth in high-volumecenters was temporally related to the introduction of endo-
vascular techniques. Anderson et al20 reported in 2004 that
the adoption of EVAR in New York state was first seen at
large academic centers; however, they demonstrated a rapid
diffusion of EVAR to nonacademic centers. In contrast, we
found that that a greater proportion of academic centers
compared with low-volume centers offered EVAR through
the study period. Our findings are similar to Forbes et al,16
who showed a centralization of AAA patients within Can-
ada; yet, our findings are the first of their kind to show a
reduction in the number of low-volume centers.
The observed in-hospital mortality for AAA repair was
3.5%. Similar to prior reports,2,4,5,21 we found a significant
improvement in survival for patients who were treated at
high-volume centers compared with medium- and low-
volume centers. In our study, mortality was 4.9% at low-
volume centers and 2.7% for high-volume centers. Starting
in the late 1990s, the volume-outcome relationship became
a topic of immense interest, and various publications exam-
ined the feasibility of the regionalization of AAA repair.22
Utilizing these data, Dudley et al23 analyzed AAA repair
and 10 other conditions and concluded that approximately
600 deaths in California could be prevented through the
regionalization of care.
First in 2001,6 and then again in 2003, the Leapfrog
Group recommended to its members that complex opera-
tions should be performed at high-volume centers.7
McPhee et al24 concluded in 2007 that regionalization of
pancreatectomy may have occurred between 1998 and
2003 due to calls for the centralization of this procedure.
We found that the public pressure exerted by the develop-
ment of the volume–outcome relationship may have con-
tributed to the regionalization of AAA repair, but it appears
that the adoption of EVAR technology has played a more
significant role. Etiologic factors cannot be definitively
established in this observational study.
Our data suggest that as the regionalization of AAA repair
occurred, a simultaneous reduction took place in in-hospital
mortality from4.2% to 2.6%, an annual improvement of 9.1%.
The lower perioperative mortality rate of 4.4% for EVAR
compared with 1.2% for traditional open repair observed in
this study agrees with prior reports11-13,25 and was likely a
factor in the temporal improvements in patient mortality after
AAA repair. Specifically, as the number of AAAs treated by
aortic stent grafts increased, the overall mortality rate for AAA
repair would have dropped because the survival advantage for
EVAR was more prominent.
Another factor leading to the observed reduction of
patient mortality after AAA repair may have been regional-
ization of care to high-volume centers. The referral of
patients to high-volume centers and the introduction of
EVAR were intimately related. High-volume centers were
more likely to perform EVAR compared with low-volume
centers; thus, it is impossible to determine whether the
improvements in survival demonstrated between 1998 and
2004 were secondary to more patients being treated at
high-volume centers or due to an increased likelihood that
patients would undergo endovascular repair.
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patients were referred to high-volume centers and that
these centers were more likely to perform endovascular
repair. We propose that referring physicians may have re-
ferred additional patients to high-volume centers specifi-
cally for endovascular treatment. We further conclude that
if patients are referred to higher-volume centers for the
purpose of receiving novel types of treatment, such as
EVAR, then a type of regionalization has occurred and that
this regionalization subsequently improved patient sur-
vival.
We have shown that the regionalization of patients
undergoing AAA repair was associated with a reduction in
patientmortality; however, widespread regionalizationmay
have some potential disadvantages. Forbes et al16 argue
that the regionalization of elective AAA repair in Canada
has led to long travel times for patients. Others have hy-
pothesized that increased regionalization may lead to a
reduction in patient survival secondary to worsening of
patient access to needed treatments. Petersen et al26 dem-
onstrated that patients followed up exclusively within the
Veterans Administration (VA) system were less likely to
undergo angiography compared with veterans who were
followed at fee-for-service institutions. They concluded
that this was due to the regionalization of the VA system
and the subsequent lack of on-site angiography at most VA
centers.26
Another area in which the regionalization of elective
AAA repair could have a deleterious effect is in the care of
ruptured AAA. If smaller hospitals are performing fewer
elective AAA repairs, then the care of patients with ruptured
AAA, who are unable to be transported to high-volume
centers, may be deleteriously affected due to waning expe-
rience.
Our finding that women have significantly increased
mortality after AAA repair corresponds to previously pub-
lished work.25,27 The finding that nonwhites were more
likely to undergo operation at low-volume centers may help
to explain historically poorer outcomes for nonwhites who
have vascular or cardiovascular procedures.28-30 This ineq-
uity warrants further study, because reducing the number
of nonwhites who undergo operation at low-volume cen-
ters may improve overall survival in this demographic
group.
The protective effect of diabetes was unexpected. Pos-
sible factors contributing to this should be further investi-
gated and are likely to be secondary to bias within the data
set. One possibility is that patients with diabetes are closely
monitored by physicians, leading to the observed survival
benefit.
Our data also show that high-volume centers are treat-
ing a greater proportion of older patients. One possible
explanation for this observation could be that surgeons at
low-volume centers selectively refer older, more complex
patients to larger-volume centers. The advent of EVAR
may have exaggerated this tendency because the benefits of
EVAR compared with open AAA repair are more pro-
nounced in elderly and high-risk patients.This study is by definition limited by the confines of the
NIS. As with any administrative database, differentiating
comorbid diseases from perioperative complications is dif-
ficult.31,32 However, the comorbidity software used in this
study has been previously validated for large data sets.18,19
Ensuring equal case mix between volume clusters is also
impossible. However, since 1998 the NIS has been
weighted to provide a consistent mix of hospitals.17 The
present study used in-hospital mortality as the main out-
come measure. Long-term survival is unavailable from the
NIS. Other important considerations, such as functional
outcomes, are difficult if not impossible to determine from
large national databases.
Despite these limitations, this study observed a trend of
improved survival for elective AAA repair that is consistent
with the introduction of EVAR technology and the region-
alization of elective AAA repairs to higher-volume centers.
We believe that our study suggests that the development of
new technology at high-volume centers may create a mech-
anism for these hospitals to offer safer operations compared
with low-volume centers. Furthermore, the development
of new technology may provide an impetus for the selective
referral of patients to these “cutting-edge” high-volume
centers, possibly playing a more significant role in region-
alization than factors such as the recommendations from
groups within the health care system.
CONCLUSION
Examining the time frame between 1998 and 2004,
this study is the first to demonstrate that regionalization of
AAA repair has occurred in the United States. Whether this
regionalization is secondary to the introduction of EVAR
or a consequence of external forces promoting regionaliza-
tion requires further research. We have shown that the
regionalization of AAA repair was temporally related to a
clinically significant improvement in patient survival. Con-
tinued regionalization of care or the development of newer
technologies, or both, may provide a mechanism to further
improve patient morbidity and mortality.
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patients undergoing repair of an abdominal aortic
aneurysm between 1988 and 2004
Comorbidity Overall
Hospital volume level
Low Medium High
Diabetes mellitus, % 10.3 9.4 10.5 10.8
Liver failure, % 0.9 0.9 0.9 0.7
Renal failure, % 3.7 3.7 3.8 3.4
Congestive heart failure, % 0.4 0.5 0.4 0.4
